Analytes/procedures in
bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).
This program is designed for laboratories utilizing APOE testing for hyperlipoproteinemia type III and Alzheimer diseases and will test for APOE e2, APOE e3, and APOE e4.
Program Information
- Three 10.0‑μg extracted DNA specimens
Shipping Schedule
-
Shipment A: February 27
-
Shipment B: September 11